# Hyperthermic Intraperitoneal Chemotherapy for Treatment of Relapsed Ovarian Cancer

> **NCT03717610** · NA · UNKNOWN · sponsor: **Uppsala University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Ovarian Cancer Recurrent

## Interventions

- **PROCEDURE:** radical surgery with HIPEC

## Key facts

- **NCT ID:** NCT03717610
- **Lead sponsor:** Uppsala University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-04
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-10-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03717610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03717610, "Hyperthermic Intraperitoneal Chemotherapy for Treatment of Relapsed Ovarian Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03717610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*